NuPathe, Inc. (PATH) Reports Q1 Loss of $0.68
NuPathe, Inc. (NASDAQ: PATH) reported Q1 EPS of ($0.68), versus ($0.43) reported last year.
Research and development expenses were ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Research and development expenses were ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
